未找到相关数据
A phase Ib/II study evaluating activity and tolerability of BTK inhibitor PCI-32765 and ofatumumab in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and related diseases.
被引：1
作者：
Jaglowski, Samantha Mary
Jones, Jeffrey Alan
Flynn, Joseph M.
Andritsos, Leslie A.
Maddocks, Kami J.
Blum, Kristie A.
Grever, Michael R.
Geyer, Susan Michelle
Woyach, Jennifer Ann
Johnson, Amy J.
Heerema, Nyla A.
Molnar, Erin
Stefanos, Mona
Devlin, Susan
Navarro, Tasheda
James, Danelle Frances
Lowe, Ann M.
Hedrick, Eric
Byrd, John C.
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Pharmacyclics, Sunnyvale, CA USA
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6508
引用
收藏
页数：1
相关论文